Drugs / FRD001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06556342 | Jul 2024 → Jul 2028 expected | ovarian cancer | Tongji Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FRD001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06556342 ↗ |
| Modality | Diagnostic / imaging agent | “ultrasound contrast agent” NCT06556342 ↗ |